Propofol 2%: Understanding a New Concentration of a Well-known Medication
Overview
Overview
Journal
Proc (Bayl Univ Med Cent)
Specialty
General Medicine
Date
2021 Aug 30
PMID
34456502
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Safety of Extended Propofol Infusions in Critically Ill Pediatric Patients.
Moas D, Aydin E, Irazuzta J, Filipp S, Guthrie K, Manasco K Cureus. 2024; 16(5):e59948.
PMID: 38854299 PMC: 11162280. DOI: 10.7759/cureus.59948.
References
1.
Morales-Garcia C
. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med. 2001; 29(2):317-22.
DOI: 10.1097/00003246-200102000-00018.
View
2.
Erden I, Gulmez D, Pamuk A, Akincia S, Hascelik G, Aypar U
. The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not. Braz J Anesthesiol. 2014; 63(6):466-72.
DOI: 10.1016/j.bjane.2012.10.003.
View
3.
Ohashi K, Dalleur O, Dykes P, Bates D
. Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf. 2014; 37(12):1011-20.
DOI: 10.1007/s40264-014-0232-1.
View
4.
Truitt E, Thompson R, Blazey-Martin D, NiSai D, Salem D
. Effect of the Implementation of Barcode Technology and an Electronic Medication Administration Record on Adverse Drug Events. Hosp Pharm. 2016; 51(6):474-83.
PMC: 4911988.
DOI: 10.1310/hpj5106-474.
View